Key Takeaways
- The sixth international congress on Biotechnology will be held in Tehran from October 22 to 24, focusing on biotechnology’s role in economic development.
- The event aims to connect science, industry, and markets, promoting advancements in various biotechnological fields.
- Iran’s biopharmaceutical industry is expanding, exporting products to 35 countries and significantly reducing foreign currency expenditures.
Biotechnology Congress Scheduled in Tehran
The sixth international congress on Biotechnology will take place from October 22 to 24 at Shahid Beheshti University in Tehran. This event, themed “Biotechnology: A Key Driver in the Development of a Modern Economy,” aims to promote biotechnology’s impact on health, agriculture, and industry.
This congress will facilitate the exchange of the latest scientific advancements and enhance collaboration between researchers and policymakers. It will serve as a platform to underscore biotechnology’s critical role in overcoming challenges in the environmental, industrial, agricultural, health, and food sectors. Networking opportunities will link national and global communities to further develop biotechnological sciences and the bioeconomy.
Focused on connecting science with industry and market, the congress will showcase strategic biotechnologies such as genetic engineering, genome editing, synthetic biology, omics technologies, bioinformatics, and artificial intelligence. Participating experts will review new findings, share resources, and explore investment and commercialization opportunities.
In addition to the main events, specialized meetings and workshops for professors and students will take place. The dynamic growth of biotechnology in recent decades has propelled competition among nations and companies, resulting in significant innovations, particularly in therapeutics such as gene therapies. These treatments, however, often come with high costs ranging from one to several million dollars per patient. Innovations in next-generation sequencing (NGS) technologies are advancing rapidly, fostering a competitive landscape that aims to improve accuracy and reduce costs, making these methods standard in laboratories worldwide.
Iran has witnessed notable growth in its biotech export sector, sending products to 35 countries in the past year, compared to 33 in the previous year. The pharmaceutical biotechnology sector alone saves approximately two billion dollars in foreign currency annually, constituting 60 percent of the nation’s pharmaceutical exports. This information was shared by Hossein Amirazodi, secretary general of the pharmaceutical biotechnology producers and exporters association, during the 4th International Conference and Exhibition on Iranian Medical Biotech Products (Iran Bio) held in February.
Over the past 30 years, Iran has successfully developed 40 of the 150 types of pharmaceutical biotechnology products available globally. Iran Bio aims to highlight the capabilities of national industries, promote information and technology transfer, and support domestic producers by expanding market opportunities and exports. These initiatives reflect Iran’s commitment to enhancing its position in the global biotechnology landscape.
The content above is a summary. For more details, see the source article.
